Esophageal cancer

Esophageal cancer is a malignant tumor arising from the lining of the esophagus, often detected late due to vague symptoms. It’s a serious condition with a generally poor prognosis if not caught early, but outcomes are improving with earlier detection and advances in treatment.


🧬 Types of Esophageal Cancer

1. Adenocarcinoma (AC)

  • Arises from glandular cells in the lower esophagus.
  • Most common in Western countries.
  • Typically develops from Barrett’s esophagus (a complication of GERD).

2. Squamous Cell Carcinoma (SCC)

  • Arises from squamous epithelial cells in the upper or middle esophagus.
  • More common worldwide, especially in Asia and parts of Africa.
  • Associated with smoking, alcohol, and dietary factors.

⚠️ Risk Factors

Adenocarcinoma (AC)Squamous Cell Carcinoma (SCC)
Chronic GERDSmoking
Barrett’s esophagusAlcohol abuse
ObesityLow fruit/vegetable intake
Male genderAchalasia
Age > 50Hot beverage consumption (repeated scalding)
SmokingHPV (possible role)

😖 Symptoms

Usually appear late in disease:

  • Dysphagia (trouble swallowing—first solids, then liquids)
  • Weight loss
  • Chest or back pain
  • Regurgitation or vomiting
  • Hoarseness (if recurrent laryngeal nerve involved)
  • Cough, especially with aspiration
  • Hematemesis or melena (rare)

🧪 Diagnosis

1. Upper Endoscopy (EGD) with Biopsy

  • First-line test for suspicious symptoms.
  • Allows visualization and tissue sampling.

2. Barium Swallow (Esophagram)

  • May show a “apple core” or irregular narrowing.

3. CT, PET-CT, Endoscopic Ultrasound (EUS)

  • Used to stage the cancer and evaluate spread to lymph nodes or organs.

4. Bronchoscopy

  • If tumor is near the trachea, to assess airway invasion.

📊 Staging (TNM System)

StageDescription
IConfined to the mucosa/submucosa
IIInvades muscular layers or local nodes
IIISpread to nearby organs or extensive lymph nodes
IVDistant metastasis (e.g., liver, lungs, bone)

💊 Treatment

🩺 Depends on stage, location, and patient condition:

Treatment TypeUsed For
Surgery (Esophagectomy)Localized disease; may be curative
Chemoradiotherapy (CRT)Before surgery (neoadjuvant) or as primary therapy
Endoscopic therapiesEarly tumors (e.g., EMR, RFA)
ImmunotherapyAdvanced/metastatic disease (e.g., PD-1 inhibitors)
Targeted therapyFor HER2-positive adenocarcinoma
Palliative stenting or feeding tubeAdvanced, non-curable cases for symptom relief

🧠 Prognosis

Stage5-Year Survival Rate (approx.)
Early stage (I)40–70%
Locally advanced (II–III)20–40%
Metastatic (IV)<5–10%

Early detection is key to improving survival.


🛡️ Prevention & Surveillance

  • Treat and monitor GERD and Barrett’s esophagus
  • Stop smoking and alcohol
  • Maintain a healthy weight
  • Diet rich in fruits and vegetables
  • Surveillance endoscopy for high-risk patients (e.g., Barrett’s with dysplasia)

🔄 Barrett’s Esophagus → Adenocarcinoma Sequence

  1. GERD
  2. Barrett’s esophagus
  3. Low-grade dysplasia
  4. High-grade dysplasia
  5. Esophageal adenocarcinoma

Call Now Button